On 16th July, Prosemble had the opportunity to present to a panel of expert judges at Cancer Research UK as part of the grant awards process and Phase II selection for the Cancer Tech Accelerator (CTA). Our presentation was followed by a detailed Q&A session, with thoughtful and rigorous questions from the panel, reflecting the high standards of the programme. We’re proud to have shared our vision and progress, and we’re now awaiting the outcome, expected in August. Fingers crossed—and grateful for the continued support from the CTA and Cancer Research UK communities.